Move clinical trial data sharing from an option to an imperative

Andy

Andy

Retired committee member
Data from clinical trials have long been locked away, some in this principal investigator’s computer bank, some in that pharmaceutical company’s cloud. For years we have been talking about opening up those vaults and freeing these data. The key has finally turned: Data sharing is becoming the new reality.

From Jan. 1, 2019, onward, the world’s leading medical journals, including the New England Journal of Medicine, the Lancet, Annals of Internal Medicine, BMJ, and thousands more require authors to disclose whether and how they plan to share deidentified raw data from individual participants in their clinical trials. What’s more, researchers wishing to publish in these journals must declare their data-sharing plans in a public registry, such as ClinicalTrials.gov.
Click to expand...
https://www.statnews.com/2019/02/19/data-sharing-imperative-clinical-trials/
 
And fortunately we have the trial meeting group notes where the PACE team agree on the steps they need to take (and will take) to prepare the data so it's ready to go whenever they are dragged kicking and screaming into doing what they have refused to do for years, despite the HRA's pathetic whitewash.

Weird how the nothingness (embarrassing reanalysis aside) that happened when data were partially released, despite apocalyptic warnings from PACE authors, is conveniently ignored when they reiterate the "danger" of releasing data to "borderline psychopaths" (and, I guess, "whiners"). Although, to be fair, the embarrassment was pretty bad for their overhyped claims.
 
You must log in or register to reply here.
Back
Top Bottom